Helix

See how curated clinico-genomic data can define high-quality MASH cohorts, reveal risk, and enable recall for deeper phenotyping. In this on-demand session, Dr. Cassie Hajek and Dr. Joseph Grzymski share a case study spanning cohort design, exclusions, noninvasive tests, and outcomes.

See how curated clinico-genomic data can define high-quality MASH cohorts, reveal risk, and enable recall for deeper phenotyping. Learn how Helix and Renown Health are using this approach to identify at-risk patients earlier, improve the accuracy of noninvasive diagnostics, and design better clinical studies and treatments for metabolic liver disease.

Health systems are redefining how they manage high-risk populations. Learn how integrated risk models combine genetic and clinical data to predict GLP-1 response, anticipate CKD progression, and guide smarter resource allocation. Watch the on-demand webinar.

Health systems are identifying risk earlier than ever, but how do you turn insight into action? In this on-demand session, Craig Newman and Dr. Cassie Hajek share how population genomics is helping leaders improve adherence, close care gaps, and drive better outcomes.

See how genetic risk influences LDL reduction and cardiovascular outcomes in patients on statin therapy. In this on-demand webinar, Dr. Liz Cirulli shares new findings from the Helix Research Network on how polygenic scores can guide earlier, more effective prevention strategies.